View all news

LENSAR to Participate in Two Upcoming Investor Conferences

February, 10, 2022

LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer, will participate in two upcoming investor conferences:

  • BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
    Fireside Chat on Wednesday, February 16 at 9:30 a.m. Eastern Time
  • 11th Annual SVB Leerink Global Healthcare Conference
    Fireside Chat on Thursday, February 17 at 2:20 p.m. Eastern Time

The SVB Leerink fireside chat can be accessed live through the Investors section of the Company's website at https://ir.lensar.com. The webcast will be available for one month after the presentation has been posted.

BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the event, please contact your BTIG representative with interest.

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

Contacts:
Thomas R. Staab, II, CFO
ir.contact@lensar.com

Lee Roth / Cameron Radinovic
Burns McClellan for LENSAR
lroth@burnsmc.com / cradinovic@burnsmc.com

Source: LENSAR, Inc.

Multimedia Files:

Categories: Press Releases
View all news